Want to join the conversation?
$MRK said it received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for approval of ZEPATIER (elbasvir and grazoprevir) to treat chronic hepatitis C virus (HCV) in adult patients in the European Union.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.